Parkinson syndrome: Heterogeneity of etiology; heterogeneity of pathogenesis?

Roger L. Albin; William T. Dauer

doi:10.1212/WNL.0b013e31825dd3d0

Parkinson syndrome: Heterogeneity of etiology; heterogeneity of pathogenesis?

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	202-203
Number of pages	2
Journal	Neurology
Volume	79
Issue number	3
DOIs	https://doi.org/10.1212/WNL.0b013e31825dd3d0
State	Published - Jul 17 2012
Externally published	Yes

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.0b013e31825dd3d0

Cite this

@article{20baa38ffa2b4dd091c67d8a1871caaa,

title = "Parkinson syndrome: Heterogeneity of etiology; heterogeneity of pathogenesis?",

author = "Albin, {Roger L.} and Dauer, {William T.}",

note = "Funding Information: R. Albin has received compensation for expert witness testimony in litigation regarding dopamine agonist induced impulse control disorders; receives grant support from the National Institutes of Health and the Dept. of Veterans Affairs; served on the Data Safety and Monitoring Boards for the QE3 and HORIZON trials; and serves on the Scientific Advisory Board of the Hereditary Disease Foundation and the Medical Advisory Board of the International Rett Syndrome Foundation. W. Dauer is on the Scientific Advisory Boards of the Parkinson Disease Foundation, Dystonia Medical Research Foundation and Bachmann-Strauss Dystonia & Parkinson Foundation; and receives grant support from the National Institutes of Health. Go to Neurology.org for full disclosures.",

year = "2012",

month = jul,

day = "17",

doi = "10.1212/WNL.0b013e31825dd3d0",

language = "English (US)",

volume = "79",

pages = "202--203",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Parkinson syndrome

T2 - Heterogeneity of etiology; heterogeneity of pathogenesis?

AU - Albin, Roger L.

AU - Dauer, William T.

N1 - Funding Information: R. Albin has received compensation for expert witness testimony in litigation regarding dopamine agonist induced impulse control disorders; receives grant support from the National Institutes of Health and the Dept. of Veterans Affairs; served on the Data Safety and Monitoring Boards for the QE3 and HORIZON trials; and serves on the Scientific Advisory Board of the Hereditary Disease Foundation and the Medical Advisory Board of the International Rett Syndrome Foundation. W. Dauer is on the Scientific Advisory Boards of the Parkinson Disease Foundation, Dystonia Medical Research Foundation and Bachmann-Strauss Dystonia & Parkinson Foundation; and receives grant support from the National Institutes of Health. Go to Neurology.org for full disclosures.

PY - 2012/7/17

Y1 - 2012/7/17

UR - http://www.scopus.com/inward/record.url?scp=84866129072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866129072&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e31825dd3d0

DO - 10.1212/WNL.0b013e31825dd3d0

M3 - Editorial

C2 - 22722622

AN - SCOPUS:84866129072

SN - 0028-3878

VL - 79

SP - 202

EP - 203

JO - Neurology

JF - Neurology

IS - 3

ER -

Parkinson syndrome: Heterogeneity of etiology; heterogeneity of pathogenesis?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this